ITGB3 and osteosarcoma: The ratios of ITGB3‐positive (ITGB3+), Ki67‐positive (Ki67+), and ITGB3+/Ki67+ double‐positive (Figure 1E) osteosarcoma cells in the recurrence groups were significantly higher than those in the primary groups, which was in agreement with our prediction.